Council Members in this Study Group: 317
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Hany SalamaVice President, Commercial Operations
NEOSTRATA COMPANY, INC. ![]()
Hany Salama, ME, MBA, CPM, is the Vice President, Commercial Operations at The NeoStrata Company. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible for all new commercial productlaunches...
Principal
Tarplin Strategies, LLC ![]()
Richard Tarplin is the founder of Tarplin Strategies in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and health care sectors. He served for almost 20 years in the US House of Representatives and US Senate and as a senior PresidentialExecutive...
System Director of Purchasing
HALLMARK HEALTH SYSTEM, INC. ![]()
Louis Rocco is the System Director of Purchasing at Hallmark Health System, in Massachusetts. He has over 25 years of experience in purchasing and has negotiation, analytical, reporting and communication skills in inventory, distribution, purchasing, mailroom, reimbursement and accounts payable background....
Stephen BentPartner
FOLEY & LARDNER LLP ![]()
Stephen A. Bent is Partner and former co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr. Bent specializes on the legal issues associated...
Principal
Law Offices of Michael D. McNeely ![]()
Michael McNeely is in private practice in Washington, DC, where he provides antitrust counseling and representation. Mr. McNeely consults on the antitrust and antitrust agency aspects of mergers, generic drug approvals, telecommunications, patents, standard setting, and other topics. He also represents...
Eric Gruff, PhD MBAPrincipal
E4 Consulting ![]()
Eric Gruff, PhD, MBA, BS, is Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has over 17 years of experience in the pharmaceutical and biotech sector, including leadership roles at Pfizer, Agouron Pharmaceuticals,...
Ken PowellPresident
Genesis Business Development, LLC ![]()
Ken Powell is the President of Genesis Business Development, a healthcare consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of intellectual property, new businesses, and products in the clinical diagnostics and medical device market segments. He has knowledge...
B. Michael Silber, PHDChief of Drug Discovery R&D and Professor
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO ![]()
Michael Silber, PhD, is Professor of Neurology, Bioengineering and Therapeutic Sciences, and Chief of Drug Discovery R & D, at the Institute for Neurodegenerative Diseases, UCSF School of Medicine. He has 25 years of experience as a senior leader in Pharma and Biotech R & D, in all major diseases.Dr....
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
More Under Armour Red Flags...
November 20, 2009
Anthony Catanach, Jr., Director, DI2 Associates, LLC
Stock Jocks Punish Under Armour's Mathletes | www.cnbc.com
Under Armour's most recent 10K contains a number of financial reporting "red flags" that reflect a cavalier attitude toward financial reporting transparency.
Will Quest Acquire Vermillion?
November 20, 2009
Ken Powell, President, Genesis Business Development, LLC
Why Quest Will Acquire Vermillion | www.genomeweb.com
Quest Diagnostics has had a known relationship with Vermillion. Now that Vermillion has received FDA approval for its OVA1 in vitro diagnostic multi-variant index assay (IVDMIA) and Quest has an exclusive three year marketing license and a 17% investment in the company plus additional loans, acquisition...
What the Former SEC Chairmen Missed...
November 19, 2009
Anthony Catanach, Jr., Director, DI2 Associates, LLC
Don't Let Banks Hide Bad Assets | online.wsj.com
Conceptually, the arguments favoring fair value accounting are sound and quite appealing. Unquestionably, financial statement users will benefit from data about how a company’s assets and liabilities change in value during a reporting period. However, there are two major issues associated with fair...
What Have the Accountants Done For Us Lately?
November 19, 2009
Anthony Catanach, Jr., Director, DI2 Associates, LLC
Systemic risk legislation threatens FASB’s independence | www.accountingweb.com
Debates about the causes of the recent financial crisis have yet to focus on the inability of financial institution independent auditors to provide adequate oversight over management’s valuations of financial instruments.
Roche Receives H1N1 FDA Emergency Use Authorization
November 16, 2009
Ken Powell, President, Genesis Business Development, LLC
Roche Gets FDA EUA for H1N1 Test Kit | www.genomeweb.com
Roche has received an Emergency Use Authorization from the FDA for its RealTime ready Influenza A/H1N1 Detection Set. The new H1N1 assay is run on its MagNA Pure LC platform for nucleic acid isolation and its LightCycler 2.0 system for real-time PCR applications. Roche, the worldwide clinical diagnostics...
Leading Experts in Medical Device Experts Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
GLG Webcast: Cash Flow Manipulation- July 28, 2009 at 10:30 AM EDT/7:30 AM PDT
July 28, 2009
GLG Webcast: Growth Opportunities for Healthcare Technology Companies
April 17, 2009
GLG Webcast: Cash Flow Manipulations - July 30, 2008 at 2:00 PM EST
July 30, 2008
July 25, 2007